INTRA-CELLULAR THERAPIES, INC.

Lobbying client · New York · filed 2025 to 2025

Biopharmaceutical company.

$160,000 Reported spend

4 Filings counted

1 Firms hired

1 Bills named

Spend is reported income plus in-house expenses across 4 filings. Everything on this page is grouped by the client's LDA id (52744), not by name.

Firms hired 1

DLA PIPER LLP (US) $160,000 4 filings

Bills named in these filings 1

HR 5376
Impacts and Outcomes for Health Career Training Act

2 filings

Reported by year 1 year

2025 $160,000 4 filings

Issues lobbied 1

Health Issues 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 4
SENATE 3

Recent filings 4 total

4T

DLA PIPER LLP (US)

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $50,000 income · posted Jan 16, 2026

View → Q3

DLA PIPER LLP (US)

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $50,000 income · posted Oct 16, 2025

View → Q2

DLA PIPER LLP (US)

2nd Quarter (Apr 1 - June 30) 2025 · House · $10,000 income · posted Jul 21, 2025

View → Q1

DLA PIPER LLP (US)

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $50,000 income · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.